Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.
about
N-acetylcysteine in COPD: why, how, and when?The relationship between COPD and lung cancerSystems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease.Hyperuricemia is a biomarker of early mortality in patients with chronic obstructive pulmonary diseaseEffect of oral N-acetylcysteine on COPD patients with microsatellite polymorphism in the heme oxygenase-1 gene promoter.Human primary airway epithelial cells isolated from active smokers have epigenetically impaired antiviral responsesOxidation pathway and exacerbations in COPD: the role of NAC.Dietary proteins and amino acids in the control of the muscle mass during immobilization and aging: role of the MPS response.Recommendations for the pharmacological treatment of COPD: questions and answers.Integrative Medicine for Respiratory Conditions: Asthma and Chronic Obstructive Pulmonary Disease.Effect of N-acetylcysteine supplementation on oxidative stress status and alveolar inflammation in people exposed to asbestos: a double-blind, randomized clinical trial.Crocin attenuates cigarette smoke-induced lung injury and cardiac dysfunction by anti-oxidative effects: the role of Nrf2 antioxidant system in preventing oxidative stress.Redox-dependent thiol modifications: implications for the release of extracellular vesicles.Prediction of microRNA and gene target from an integrated network in chronic obstructive pulmonary disease based on canonical correlation analysis.
P2860
Q26768289-25C46B16-3176-4B46-B8E7-64AAF160AEF3Q26781337-FE568409-6363-48A1-961A-F8BD27AD838BQ36164552-E42CB3C3-92C3-437D-A9BB-1E79B7D95173Q36332198-0811EA90-7A06-4F46-BF86-A814CD4B39FBQ36365165-94F7295E-08B0-47D6-BF5E-0EC4623AD4BAQ37237117-1D8BC134-38A6-4563-A675-236DE3D7ED93Q38633304-91168E4A-7EEF-4879-B316-281BDF303006Q39125369-E95DD06D-6E10-4EA3-98ED-26510B9D26A2Q47272746-66CA89CD-B89B-4FF4-967E-F85DE5572FB2Q47648795-64103589-6E1C-41B9-AAC6-4B8DBBDC0984Q51613006-F6CD31DF-28E1-4345-A1EE-A958EBAD8997Q52327746-616DDA96-7F2A-4791-98D1-F2CFDB3D1C9BQ55237882-9A780EE3-0053-42FF-A15E-4161CA2A8B9AQ55416564-1ABC3459-173E-41FB-81B7-6D82A3592A72
P2860
Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Update on the pathological pro ...... obstructive pulmonary disease.
@en
type
label
Update on the pathological pro ...... obstructive pulmonary disease.
@en
prefLabel
Update on the pathological pro ...... obstructive pulmonary disease.
@en
P2860
P921
P356
P1476
Update on the pathological pro ...... obstructive pulmonary disease.
@en
P2093
Cee Zhung Steven Tseng
Hoi Nam Tse
P2860
P304
P356
10.2147/COPD.S51057
P407
P577
2014-08-06T00:00:00Z